Research Presentations Financial Disclosure Statements ISPOR 6th Asia-Pacific Conference Abstracts

Research Presentations Financial Disclosure Statements ISPOR 6th Asia-Pacific Conference Abstracts

VA L U E I N H E A LT H 1 7 ( 2 0 1 4 ) A 8 1 4 - A 8 1 7 A814 DISCLOSURE INFORMATION Research Presentations Financial Disclosure Statements The Int...

44KB Sizes 0 Downloads 46 Views

VA L U E I N H E A LT H 1 7 ( 2 0 1 4 ) A 8 1 4 - A 8 1 7

A814

DISCLOSURE INFORMATION Research Presentations Financial Disclosure Statements The International Society for Pharmacoeconomics and Outcomes Research asked all abstract contributors to disclose financial support for their research. The following financial support was declared:

REFERENCE CODE

FINANCIAL SUPPORT

REFERENCE CODE

FINANCIAL SUPPORT

CN1 CN2 CN3 CN4 CV1 CV2 CV3 CV4 DB1 DB2 DB3 DB4 DU1 DU2 DU3 DU4 HC1 HC2 HC3 HC4 HS1 HS2 HS3 HS4 IN1

None HIHR HTA, Southampton, UK Pfizer (Thailand) Limited, Bangkok, Thailand None None None National Health Insurance Administration, Taiwan, Taipei, Taiwan None None Eli Lilly and Company, Indianapolis, IN, USA None Pfizer Inc., New York, NY, USA Amgen, Thousand Oaks, CA, USA None None None None Novartis Pharma AG, Basel, Switzerland Bristol-Myers Squibb, Mulgrave, Australia None None Kinapse Ltd., Wimbledon, England China Health Insurance Research Association, Beijing, China None The National Engineering Research Center Of Ultrasonic Medical Treatment, Chongqing, China GlaxoSmithKline (China) Investment Co., Ltd., Beijing, China MSD (Thailand) Ltd., Bangkok, Thailand None None None None None Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand American Cancer Society, Atlanta, GA, USA None China Medical Board, Boston, MA, USA GlaxoSmithKline, Wavre, Belgium Pfizer, Inc., New York, NY, USA Eli Lilly and Company, Indianapolis, IN, USA Eli Lilly China, Shanghai, China None Karaganda State Medical University, Karaganda, Kazakhstan None Hungarian Academy of Sciences (HAS) Bolyai János Research Fellowship, Budapest, Hungary; University of Pécs, Faculty of Health Sciences, Pécs, Hungary None None None None Boehringer Ingelheim (Taiwan) Ltd., Taipei, Taiwan Celgene South Korea, Seoul, South Korea None GE Medical Systems Trade Development (Shanghai) Co. Ltd., Shanghai, China None Department of Health Philippines, Manila, Philippines; Rockefeller Foundation, New York, NY, USA; World Health Organization, Geneva, Switzerland; Health Intervention and Technology Assessment Program, Nonthaburi, Thailand; National Institute for Health and Care Excellence International, London, UK None MSD (Thailand) Ltd., Bangkok, Thailand None Celgene, Summit, NJ, USA None Pfizer (Thailand) Ltd., Bangkok, Thailand None None None National Medical Research Council, Singapore, Singapore None None

PCN38 PCN39 PCN40

SMs Consulting, Ltd., Bratislava, Slovak Republic None Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand Decision Resources Group, Burlington, MA, USA Maharishi Markandeshwar University, Ambala Haryana, India None None Bristol-Myers Squibb, Taipei, Taiwan None Hungarian Academy of Sciences (HAS) Bolyai János Research Fellowship, Budapest, Hungary; University of Pécs, Faculty of Health Sciences, Pécs, Hungary None None Pfizer, Inc., New York, NY, USA Eli Lilly and Company, Indianapolis, IN, USA Pfizer Inc., New York, NY, USA HSUM, School of Nursing, Ulaanbaatar, Mongolia None Mistry of Food and Drug Safety, Osong Health Technology Administration Complex, South Korea None None None Medtronic, Minneapolis, MN, USA Shiweida Co., Jiling, China None None None None None Medtronic, Minneapolis, MN, USA None None None St. Jude Medical, Plymouth, MN, USA Takeda Pharmaceuticals Taiwan, Ltd., Taipei, Taiwan Japan Medical Data Center Co., Ltd., Tokyo, Japan Eli-Lilly Company, Indianapolis, IN, USA None None None Glaxo, Bangkok, Thailand None None Merck Sharp & Dohme, Shanghai, China Tianjin Zhongxin Pharmaceutical Group Co., Ltd., Tianjin, China Chinese Ministry of Health, Beijing, China Pfizer, Taipei, Taiwan None Medtronic Korea, Seoul, South Korea Medtronic, Minneapolis, MN, USA Pfizer Inc., New York, NY, USA Merck & Co, Inc., North Wales, PA, USA; Nanjing Medical University, Nanjing, China None None Eli Lilly and Company, Indianapolis, IN, USA Pfizer, Inc., New York, NY, USA Chi-Mei Medical Center, Tainan, Taiwan None None None None None Amgen, Thousand Oaks, CA, USA None None None None Young Investigator Award, Sichuan University, Chengdu, China None None None

IN2 IN3 IN4 MH1 MH2 MH3 MH4 PCN1 PCN2 PCN3 PCN4 PCN5 PCN6 PCN7 PCN8 PCN9 PCN10 PCN11 PCN12

PCN13 PCN16 PCN17 PCN18 PCN19 PCN20 PCN21 PCN22 PCN23 PCN24

PCN25 PCN26 PCN27 PCN28 PCN29 PCN31 PCN32 PCN33 PCN34 PCN35 PCN36 PCN37

PCN41 PCN42 PCN44 PCN45 PCN46 PCN47 PCN48

PCV1 PCV2 PCV4 PCV5 PCV6 PCV7 PCV8 PCV9 PCV10 PCV11 PCV12 PCV13 PCV14 PCV15 PCV16 PCV17 PCV18 PCV19 PCV20 PCV21 PCV22 PCV23 PCV25 PCV26 PCV27 PCV28 PCV29 PCV30 PCV31 PCV32 PCV33 PCV34 PCV35 PCV36 PCV37 PCV38 PCV39 PCV40 PCV41 PCV42 PCV43 PCV44 PCV45 PCV46 PCV47 PCV48 PCV49 PCV50 PCV51 PCV52 PCV53 PCV54 PCV55 PCV56 PCV57 PCV58 PDB1 PDB2 PDB3 PDB4

Copyright © 2014, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.

A815

VA L U E I N H E A LT H 1 7 ( 2 0 1 4 ) A 8 1 4 - A 8 1 7

REFERENCE CODE

FINANCIAL SUPPORT

REFERENCE CODE

FINANCIAL SUPPORT

PDB5 PDB6 PDB7 PDB8 PDB9 PDB10 PDB11 PDB12 PDB13 PDB14 PDB15 PDB16 PDB17 PDB18 PDB19 PDB20 PDB21 PDB22 PDB23 PDB24 PDB25 PDB26 PDB27 PDB28 PDB29

None None Becton, Dickinson and Company, Beijing, China None None None MSD China, Beijing, China MSD China, Beijing, China Novo Nordisk, Kuala Lumpur, Malaysia None Novo Nordisk, Kuala Lumpur, Malaysia None Novo Nordisk, Mexico City, Mexico Novo Nordisk (China) Pharmaceuticals Co., Ltd., Beijing, China None Japan Medical Data Center Co., Ltd., Tokyo, Japan None Department of Health, Sichuan Province, Chengdu, China None None None Boffo - Ipsen (Tianjin) Pharmaceutical Co., Ltd., Tianjin, China Bristol-Myers Squibb, Shanghai, China None Australian National Health and Medical Research Council, Canberra, Australia None Kantar Health, New York, NY, USA None None None None None None None None None National Science Foundation, Taipei, Taiwan None Chair on adherence to Treatments, Québec, QC, Canada National Health Insurance Service, Seoul, South Korea BD, Franklin Lakes, NJ, USA Ministry of Health, Kuala Lumpur, Malaysia None None None None Roche Diagnostics (Shanghai) Co., Ltd., Shanghai, China AstraZeneca, Mississauga, ON, Canada Silpakorn University, NakornPathom Province, Thailand None None Aga Khan University, Karachi, Pakistan Aga Khan University, Karachi, Pakistan; Higher Education Commission, Islamabad, Pakistan National Natural Science Foundation of China, Beijing, China National Natural Science Foundation of China, Beijing, China Delhi Society for Promotion of Rational Use of Drugs & WHO SEARO, New Delhi, India None None National Institute of Health Research and Development, Jakarta Selatan, Indonesia None None National Natural Science Foundation of China, Beijing, China None None None None None None None None None National Institute on Aging, Bethesda, MD, USA None None None None Ministry of Health, Kuala Lumpur, Malaysia; United Nation Development Programme, Kuala Lumpur, Malaysia None ASCEND Research Network, Austerlia, Australia None

PHP37 PHP38 PHP39 PHP40 PHP41 PHP42 PHP43 PHP44

Agency for Integrated Care, Singapore, Singapore None None None None Ministry of Health, Singapore, Singapore None School of Nursing, Health Science University of Mongolia, Ulaanbaatar, Mongolia Department of Health, Sichuan Province, Chengdu, China None None None None Nursing School, HSUM, Ulaanbaatar, Mongolia School of Nursing, Ulaanbaatar, Mongolia None None None None Bristol-Myers Squibb, Mulgrave, Australia None None Lancaster University, Lancaster, UK None The Alliance for Health Policy and Systems Research (AHPSR), the World Health Organization, Geneva, Switzerland; Shandong University, Jinan, China None None None None None None None None None None None None None Tehran University of Medical Sciences, Tehran, Iran China Medical Board, Boston, MA, USA None None National Health Insurance Administration, Taipei City, Taiwan None None None None None None Johnson & Johnson Medical Asia-Pacific, Singapore, Singapore None None None Department of Health, Manila, Philippines None Health Sciences University of Mongolia, School of Nursing, Ulaanbaatar, Mongolia None School of Nursing, Health Science University of Mongolia, Ulaanbaatar, Mongolia None None None None None None Ministry of Higher Education, Putrajaya, Malaysia; Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia None None ICON Clinical Research UK Ltd., London, UK None None None None None None None None MSD, China, Shanghai, China MSD, China, Shanghai, China Ministry of Education and Culture, Jakarta, Indonesia

PDB30 PDB31 PDB32 PDB34 PDB35 PDB37 PDB38 PDB39 PDB40 PDB41 PDB42 PDB43 PDB44 PDB45 PDB46 PDB47 PDB48 PGI1 PGI2 PGI3 PGI4 PGI5 PGI6 PHP1 PHP2 PHP3 PHP4 PHP5 PHP6 PHP7 PHP8 PHP9 PHP10 PHP11 PHP12 PHP14 PHP15 PHP16 PHP17 PHP18 PHP19 PHP20 PHP22 PHP23 PHP24 PHP25 PHP26 PHP28 PHP29 PHP31 PHP32 PHP33 PHP34 PHP35 PHP36

PHP46 PHP47 PHP48 PHP49 PHP50 PHP52 PHP53 PHP54 PHP55 PHP56 PHP57 PHP58 PHP59 PHP60 PHP61 PHP62 PHP63

PHP64 PHP65 PHP66 PHP67 PHP68 PHP70 PHP71 PHP72 PHP73 PHP74 PHP75 PHP76 PHP77 PHP78 PHP79 PHP81 PHP82 PHP83 PHP84 PHP85 PHP87 PHP88 PHP89 PHP90 PHP91 PHP92 PHP93 PHP94 PHP95 PHP96 PHP97 PHP98 PHP100 PHP101 PHP102 PHP103 PHP104 PHP105 PHP106 PHP107 PHP108 PHP110 PHP111 PHP113 PIH1 PIH2 PIH3 PIH4 PIH5 PIH7 PIH8 PIH10 PIH11 PIH12

VA L U E I N H E A LT H 1 7 ( 2 0 1 4 ) A 8 1 4 - A 8 1 7

A816

REFERENCE CODE

FINANCIAL SUPPORT

REFERENCE CODE

FINANCIAL SUPPORT

PIH13 PIH15 PIH16 PIH17 PIH18 PIH19 PIH20 PIH21 PIH22

None Bristol-Myers Squibb, New York, NY, USA Adheris Health, Burlington, MA, USA None None None EuroQol Group, Rotterdam, The Netherlands Eli Lilly & Company, Indianapolis, IN, USA National Evidence-based healthcare Collaborating Agency, Seoul, South Korea; EuroQol group, Rotterdam, The Netherlands Curran Foundation, Sydney, Australia; St Vincent’s Private Hospital, Sydney, Sydney, Australia Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand None None None None None None Chi-Mei medical center, Tainan, Taiwan; Ministry of Health and Welfare, Taipei, Taiwan None None None None None China Medical Board, Beijing, China None None None None MORU, Bangkok, Thailand Merck, West Point, PA, USA Kantar Health, New York, NY, USA Johnson & Johnson Medical, Shanghai, China Kantar Health, New York, NY, USA School of Nursing, Health Sciensity of Mongolia, Ulaanbaatar, Mongolia None Eli Lilly China, Shanghai, China BMS Foundation, New York, NY, USA None None Bristol-Myers Squibb, Shanghai, China None GlaxoSmithKline Vaccines, Wavre, Belgium None MSD (Thailand) Ltd., Bangkok, Thailand None Ministry of National Education, Republic of Indonesia, Jakarta, Indonesia None Department of Health, Manila, Philippines; World Health Organization, Geneva, Switzerland; Rockefeller Foundation, NewYork, NY, USA; National Institute for Health and Care Excellence, London, UK Hoffmann La Roche, New York, NY, USA None None None None None None Sanofi-Pasteur MSD, Lyon, France National AIDS Commission, Jakarta, Indonesia None None None Eli Lilly, Windlesham, UK None None None H Lundbeck AS, Valby, Denmark Lundbeck Pte Ltd., Singapore, Singapore Janssen Asia Pacific, Singapore, Singapore None None None None Richter Gedeon Nyrt., Budapest, Hungary None Richter Gedeon Nyrt., Budapest, Hungary None Lundbeck Pte Ltd., Singapore, Singapore Lundbeck Pte Ltd., Singapore, Singapore Neopharm, Taejun, South Korea

PMH23 PMH25 PMH26 PMH27 PMH29 PMH30 PMH32 PMH33 PMH34 PMH35 PMH36 PMS1 PMS2

None None None Restore FX, Austin, TX, USA Pfizer Pharmaceuticals Korea Ltd., Seoul, South Korea Universiti Sains Malaysia, Pulau Pinang, Malaysia None Japanese Ministry of Health, Labour and Welfare, Tokyo, Japan Hejrat Distribution Company, Tehran, Iran None Mahasarakham University, Maha Sarakham, Thailand Eli Lilly and Company, Indianapolis, IN, USA National Natural Science Foundation (81172610), Beijing, China; the national science and technology Huimin project (2012GS610101), Beijing, China; International cooperation projects of Shaanxi Province (2012, kw-43), Xi’an, China; the Fundamental Research Funds for the Central Universities in China(61), Xi’an, China None the National Natural Science Foundation of China (No. 81172610), Beijing, China; national science and technology Huimin project (2012GS610101), Beijing, China; International cooperation projects of Shaanxi Province (2012, kw-43), Xi’an, China; science development fund projects of Xi’an city (GG06176), Xi’an, China; the Fundamental Research Funds for the Central Universities in China (61), Xi’an, China The scientific research project of Shaanxi Provincial Department of health: 2012D25, xi’an, China None Eli Lilly and Company, Indianapolis, IN, USA Pfizer, Beijing, China None None None None None Actelion Pharmaceuticals, Sydney, Australia None None None Janssen Cilag, Bangkok, Thailand Pfizer, Taipei, Taiwan None School of Nursing, Health Science university of Mongolia, Ulaanbaatar, Mongolia HSUM, School of Nursing, Ulaanbaatar, Mongolia Project Supported By Scientific Research Fund of Shaanxi Provincial Administration of Traditional Chinese Medicine: 13-ZY002, xi’an, China None None Johnson & Johnson, Singapore, Singapore Johnson & Johnson, Singapore, Singapore None None None None None None None National Institute for Health Research, Health Technology Assessment, Southampton, UK Kantar Health, Princeton, NJ, USA Multiple Sclerosis Research Australia, Sydney, Australia Ministry of Health, Labour and Welfare, Tokyo, Japan None None None Bristol Laboratories Ltd., Luton, UK; Manipal University, Manipal, India None None None None Ministry of Science and Technology of People’s Republic of China, Beijing, China None None Guangzhou Baiyunshan Zhongyi Pharmaceutical Company Limited, Guangzhou, China Lundbeck Pte Ltd., Singapore, Singapore None Eli Lilly and Company, Indianapolis, IN, USA Eli Lilly China, Shanghai, China None None

PIH23 PIH24 PIH25 PIH26 PIH27 PIH28 PIH29 PIH30 PIH31 PIH32 PIH33 PIH34 PIH35 PIH36 PIH37 PIN1 PIN2 PIN4 PIN5 PIN6 PIN7 PIN8 PIN9 PIN10 PIN11 PIN12 PIN14 PIN15 PIN16 PIN17 PIN18 PIN19 PIN20 PIN21 PIN22 PIN23 PIN24 PIN25 PIN26

PIN27 PIN28 PIN29 PIN30 PIN31 PIN32 PIN33 PIN34 PIN35 PMH1 PMH2 PMH3 PMH4 PMH5 PMH6 PMH7 PMH8 PMH9 PMH10 PMH11 PMH12 PMH13 PMH14 PMH15 PMH16 PMH17 PMH18 PMH19 PMH21 PMH22

PMS3 PMS4

PMS5 PMS6 PMS7 PMS8 PMS9 PMS10 PMS11 PMS12 PMS13 PMS14 PMS15 PMS16 PMS17 PMS18 PMS19 PMS20 PMS21 PMS22 PMS23

PMS24 PMS25 PMS26 PMS27 PMS28 PMS30 PMS31 PMS32 PND1 PND2 PND3 PND4 PND5 PND6 PND7 PND8 PND9 PND10 PND11 PRM1 PRM2 PRM3 PRM4 PRM5 PRM7 PRM8 PRM9 PRM10 PRM11 PRM12 PRM13 PRM14 PRM15

A817

VA L U E I N H E A LT H 1 7 ( 2 0 1 4 ) A 8 1 4 - A 8 1 7

REFERENCE CODE

FINANCIAL SUPPORT

REFERENCE CODE

FINANCIAL SUPPORT

PRM16 PRM17 PRM18 PRM19 PRM20 PRM21 PRM22 PRM23 PRM24 PRM25 PRM26 PRM27

Lundbeck Singapore Pte Ltd., Singapore, Singapore Merck & Co, Inc., North Wales, PA, USA None None Celgene South Korea, Seoul, South Korea AstraZeneca, Molndal, Sweden None None None None None National Health and Medical Research Council, Canberra, Australia Ministry of Health, Singapore, Singapore, Singapore None None None Scientific Foundation Polpharma, Starogard Gdański, Poland None National Pharmaceutical Council, Washington, DC, USA None None None NIH, Wisconsin, WI, USA None None None Merck & Co., Inc., NJ, USA Health Sciences University of Mongolia, Ulaanbaatar, Mongolia None None None None Nestlé Research Centre, Lausanne, Switzerland Nestle Nutrition Institute, Lausanne, Switzerland None None None UCB Pharma China, Inc., Shanghai, China Nestle Nutrition Institute, Lausanne, Switzerland None Vifor Pharma Ltd., Glattbrugg, Switzerland Institutional Clinical and Translational Science Award, NIH/NCATS Grant Number UL1TR000001, Kansas City, MO, USA None None None None None UCB Pharma, Shanghai, China

PRS26 PRS27 PRS28 PRS29 PSS1 PSS2 PSS3 PSS4 PSS5 PSS6 PSS7 PSS8 PSS9 PSS10 PSS12 PSS13 PSY1 PSY2 PSY3 PSY4 PSY5 PSY6 PSY7 PSY8 PSY9 PSY10 PSY11

Pfizer Inc., Beijing, China None None Universiti Sains Malaysia, Kota Bharu, Malaysia None Galderma Laboratories, L.P., Ft. Worth, TX, USA None Novartis, Beijing, China None None Beijing Novartis Pharma Ltd., Beijing, China None Janssen Cilag, Bangkok, Thailand Pfizer Pharmaceuticals Korea Ltd., Seoul, South Korea Shandong University, Jinan, China None None None None None None None None Pfizer Pharmaceuticals Korea Ltd., Seoul, South Korea None Mundipharma Research GmbH & Co. KG, Limburg, Germany Health Science University of Mkngolia, School of Nursing, Ulaanbaatar, Mongolia None None None None None Baxter Heathcare Corporation, Deerfield, IL, USA Baxter Heathcare Corporation, Deerfield, IL, USA Beijing Novartis Pharma Co., Ltd., Beijing, China GlaxoSmithKline, Hong Kong, Hong Kong None None Pfizer Pharmaceuticals Korea, Ltd., Seoul, South Korea None None National University of Singapore, Singapore, Singapore Costello Medical Consulting Ltd., Cambridge, UK None None None None Kantar Health, Princeton, NJ, USA Pfizer Pharmaceuticals Korea Ltd., Seoul, South Korea

PRM28 PRM29 PRM31 PRM32 PRM33 PRM34 PRM35 PRM36 PRM37 PRM38 PRM39 PRM40 PRS1 PRS2 PRS3 PRS4 PRS5 PRS7 PRS8 PRS9 PRS10 PRS11 PRS12 PRS13 PRS14 PRS15 PRS16 PRS17 PRS18 PRS19 PRS20 PRS21 PRS22 PRS23 PRS24 PRS25

PUK1 PUK2 PUK3 PUK5 PUK6 PUK7 PUK8 PUK9 PUK10 PUK11 PUK13 PUK14 PUK15 PUK16 QA1 QA2 QA3 QA4 RR1 RR2 RR3 RR4